August 13, 2025

Medical Oddities: Spud Alert, Method Matters Most

Science spans snacks, cells, sheep, and sips in this week’s research highlights.

Conexiant

August 12, 2025

FDA Approves First Therapy for Non-cystic Fibrosis Bronchiectasis

Brensocatib (Brinsupri) will offer a new treatment option for patients 12 years and older.

Conexiant

August 05, 2025

Nature’s Mouthwash: Better Breath, Fewer Risks?

Researchers report significant improvements in breath odor and oral health after four weeks using a natural essential oil rinse in patients with obesity and periodontitis.

Conexiant

August 01, 2025

UTI Linked to Short-Term Spike in MI, Storke

Analysis of microbiologically confirmed UTIs reveals a transient increase in cardiovascular event rates, especially within 7 days of infection onset.

Conexiant

July 21, 2025

Stanford Physician-Scientist Takes CDER Helm

Stanford's George Tidmarsh appointed FDA's new CDER director, bringing 30+ years biotechnology experience and seven approved drugs.

Conexiant

July 01, 2025

Five Gynecologic Conditions Linked with Bladder Pain

A new international consensus identifies five gynecologic conditions commonly linked with interstitial cystitis/bladder pain syndrome, urging clinicians to adopt a multidisciplinary and trauma-informed approach to care.

Conexiant

June 20, 2025

Gut Bacteria Predict Chemotherapy-Related Heart Damage

Specific gut bacteria correlate with biomarkers indicating increased risk of cardiotoxicity in breast cancer patients before chemotherapy treatment.

Conexiant

June 18, 2025

Are CBD Compounds Effective Antifungals?

CBD and CBDV exhibit antifungal activity against Cryptococcus neoformans and dermatophytes in vitro and improve survival in an in vivo model.

Conexiant

July 08, 2025

Early Gut Microbiota Predicts GDM

Gut microbiota profiles at 11–13 weeks of pregnancy distinguished women who later developed gestational diabetes mellitus with high diagnostic accuracy.

Conexiant